These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 33194317)

  • 1. No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study.
    Ascierto PA; Marincola FM; Fox BA; Galon J
    Oncoimmunology; 2020 Oct; 9(1):1826132. PubMed ID: 33194317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance).
    Lee H; Sha D; Foster NR; Shi Q; Alberts SR; Smyrk TC; Sinicrope FA
    Ann Oncol; 2020 Apr; 31(4):487-494. PubMed ID: 32165096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of risk assessment in colon cancer: immunity is key.
    Hijazi A; Galon J
    Oncoimmunology; 2024; 13(1):2347441. PubMed ID: 38694625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147.
    Phipps AI; Shi Q; Limburg PJ; Nelson GD; Sargent DJ; Sinicrope FA; Chan E; Gill S; Goldberg RM; Kahlenberg M; Nair S; Shields AF; Newcomb PA; Alberts SR;
    Int J Cancer; 2016 Sep; 139(5):986-95. PubMed ID: 27060850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors.
    Eljilany I; Saghand PG; Chen J; Ratan A; McCarter M; Carpten J; Colman H; Ikeguchi AP; Puzanov I; Arnold S; Churchman M; Hwu P; Conejo-Garcia J; Dalton WS; Weiner GJ; El Naqa IM; Tarhini AA
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts.
    Taieb J; Basile D; Seligmann J; Argiles G; André T; Gallois C; Goldberg RM; Yothers G; Sobrero A; Meyerhardt JA; Souglakos J; Labianca R; Iveson T; Church DN; Arnold D; Tie J; Gill S; Laurent-Puig P; Yoshino T; Lonardi S; Shi Q
    Eur J Cancer; 2024 Jul; 206():114118. PubMed ID: 38810317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease.
    Luke JJ; Davar D; Andtbacka RH; Bhardwaj N; Brody JD; Chesney J; Coffin R; de Baere T; de Gruijl TD; Fury M; Goldmacher G; Harrington KJ; Kaufman H; Kelly CM; Khilnani AD; Liu K; Loi S; Long GV; Melero I; Middleton M; Neyns B; Pinato DJ; Sheth RA; Solomon SB; Szapary P; Marabelle A
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38641350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552].
    Hartlapp I; Valta-Seufzer D; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens UM; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Anger F; Germer CT; Stang A; Kimmel B; Heinemann V; Kunzmann V;
    ESMO Open; 2024 May; 9(5):103463. PubMed ID: 38703429
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness and robustness of Immunoscore for personalized management of cancer patients.
    Marliot F; Pagès F; Galon J
    Oncoimmunology; 2020 Oct; 9(1):1832324. PubMed ID: 33194318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies.
    Benavente S; Sánchez-García A; Naches S; LLeonart ME; Lorente J
    Front Oncol; 2020; 10():582884. PubMed ID: 33194719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer.
    El Sissy C; Kirilovsky A; Zeitoun G; Marliot F; Haicheur N; Lagorce-Pagès C; Galon J; Pagès F
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33805758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. License to kill: microsatellite instability and immune contexture.
    Maby P; Bindea G; Mlecnik B; Galon J
    Oncoimmunology; 2021 Apr; 10(1):1905935. PubMed ID: 33868790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiverse of immune microenvironment in metastatic colorectal cancer.
    Van den Eynde M; Mlecnik B; Bindea G; Galon J
    Oncoimmunology; 2020 Sep; 9(1):1824316. PubMed ID: 33457100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual biopsy using CT radiomics for evaluation of disagreement in pathology between endoscopic biopsy and postoperative specimens in patients with gastric cancer: a dual-energy CT generalizability study.
    Liu Y; Zhao S; Wu Z; Liang H; Chen X; Huang C; Lu H; Yuan M; Xue X; Luo C; Liu C; Gao J
    Insights Imaging; 2023 Jul; 14(1):118. PubMed ID: 37405591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep radiomic model based on the sphere-shell partition for predicting treatment response to chemotherapy in lung cancer.
    Chang R; Qi S; Wu Y; Yue Y; Zhang X; Guan Y; Qian W
    Transl Oncol; 2023 Sep; 35():101719. PubMed ID: 37320871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from
    Li J; Zhang C; Guo H; Li S; You Y; Zheng P; Zhang H; Wang H; Bai J
    Front Immunol; 2022; 13():1019386. PubMed ID: 36311742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.
    Mlecnik B; Torigoe T; Bindea G; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Hirohashi Y; Furuhata T; Takemasa I; Patel P; Vora H; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Yoshino T; Taniguchi H; Bifulco C; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert CI; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang J; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson E; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Marliot F; Fredriksen T; Buttard B; Lafontaine L; Maby P; Majdi A; Hijazi A; El Sissy C; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; Van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Marincola FM; Ascierto PA; Fox BA; Pagès F; Kawakami Y; Galon J
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics in precision medicine for gastric cancer: opportunities and challenges.
    Chen Q; Zhang L; Liu S; You J; Chen L; Jin Z; Zhang S; Zhang B
    Eur Radiol; 2022 Sep; 32(9):5852-5868. PubMed ID: 35316364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographical Evaluation of Tumor Immunosuppressive Microenvironment and Treatment Outcomes in Gastric Cancer: A Retrospective, Multicohort Study.
    Lin JX; Lin JP; Weng Y; Lv CB; Chen JH; Zhan CY; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zhou WX; Zhang XJ; Zheng CH; Cai LS; Ma YB; Huang CM
    Ann Surg Oncol; 2022 Aug; 29(8):5022-5033. PubMed ID: 35294651
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.